Publications by authors named "Daryl Barnett"

Claim this Profile
T
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Daryl Barnett

Curr Cancer Drug Targets· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.
Ronan J Kelly, Robert W Robey, Clara C Chen, Deborah Draper, Victoria Luchenko, Daryl Barnett

Oncologist· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
Robert W Robey, Suneet Shukla, Elizabeth M Finley, Robert K Oldham, Daryl Barnett

Biochem Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis